Back to RARE
Creative Planning RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
6
Latest value
$630K
Q3 2026
Peak value
$2.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $259K |
| Q1 2026 | $680K |
| Q2 2026 | $16K |
| Q2 2026 | $2.3M |
| Q3 2026 | $6K |
| Q3 2026 | $630K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $630K | 41.9K | — | — |
| Q3 2026 | $6K | 375 | — | — |
| Q2 2026 | $2.3M | 67.5K | — | — |
| Q2 2026 | $16K | 470 | — | — |
| Q1 2026 | $680K | 32.4K | — | — |
| Q4 2025 | $259K | 11.3K | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$219.1M
$213.3M
$205.6M
$205.6M